Carboplatin Injection, Solution
Product Images NDC 60505-6282

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Carboplatin (NDC 60505-6282). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Teyro-vial-label-15-ml (Carboplatin Injection Carton Label 150mg)

FDA Label Image

Teyro-vial-45-ml (Carboplatin Injection Carton Label 450mg)

Teyro-vial-45-ml (Carboplatin Injection Carton Label 450mg)
Product Description: The text provides information about a medication called CARBOplatin which is an injection used for intravenous (IV) administration. The medication is supplied in a multi-dose vial containing 450 mg of CARBOplatin in a 45 mL solution (10 mg/mL concentration). It is important to note that CARBOplatin is a cytotoxic agent, meaning it has toxic effects on cells. The package includes a patient information leaflet, and the pharmacist is instructed to dispense it along with the medication. The solution does not contain any preservatives and is described as a sterile, non-pyrogenic, aqueous solution. The recommended dosage and detailed instructions for use can be found in the accompanying package insert. The medication should be stored at a controlled room temperature of 20°C to 25°C (66°F to 77°F) and protected from light. The medication is manufactured by Teyro Labs Private Limited in Tamil Nadu, India and distributed by Apotex Corp. in Weston, Florida. The expiration date for this product is 00/2023.*
FDA Label Image

Teyro-vial-label-5-ml (Carboplatin Injection Carton Label 50mg)

FDA Label Image

Teyro-carton-label-60-ml (Carboplatin Injection Carton Label 600mg)

FDA Label Image

Teyro-carton-15-ml (Carboplatin Injection Container Label 150mg)

Teyro-carton-15-ml (Carboplatin Injection Container Label 150mg)
This text appears to be a description of a medication called Beonly EachmL. It contains carboplatin USP in a solution of 150 mg/15 mL in water for injection USP. The medication is sterile, non-pyrogenic, and does not contain any preservatives. The usual dosage and directions for use can be found in the accompanying package insert. The medication should be stored at a temperature of 20°C to 25°C (68°F to 77°F) and protected from light. It is manufactured by Teyro Labs Private Limited in India and is distributed by Apotex Corp. The text also mentions that the medication is a cytotoxic agent and comes in a 15 mL multi-dose vial. Unfortunately, it does not provide any information about the lot number or expiration date.*
FDA Label Image

Teyro-carton-label-45-ml (Carboplatin Injection Container Label 450mg)

Teyro-carton-label-45-ml (Carboplatin Injection Container Label 450mg)
This is a description of a medication called "CARBOplatin" in the form of an injection. It is supplied in a 45 mL multi-dose vial, with each mL containing 10 mg of carboplatin USP in a solution in water for injection USP. The medication is a cytotoxic agent and is intended for intravenous use. It does not contain any preservatives and is a sterile and non-pyrogenic aqueous solution. The usual dosage and complete directions for use can be found in the accompanying package insert. The medication should be stored at a temperature between 20°C to 25°C (68°F to 77°F) and protected from light. It is manufactured by Teyro Labs Private Limited in India and is licensed under Mfg. Lic No.: TNO0005631. The medication is manufactured for Apotex Corp. in Weston, Florida. The revision date is 00/2023, and the lot number and expiration date are not available.*
FDA Label Image

Teyro-carton-label-5-ml (Carboplatin Injection Container Label 50mg)

Teyro-carton-label-5-ml (Carboplatin Injection Container Label 50mg)
This text appears to be a description of a medication called CARBOplatin. It is used for intravenous use and is a cytotoxic agent. The medication is available in a 5 mL multi-dose vial, with each mL containing 10 mg of carboplatin USP in a 50 mg /5 mL solution in water for injection USP. It does not contain any preservatives and is a sterile, non-pyrogenic, aqueous solution. The usual dosage and complete directions for use can be found in the accompanying package insert. The medication should be stored at 20°C to 25°C (68°F to 77°F) and protected from light. It is manufactured by Teyro Labs Private Limited in India for Apotex Corp. in Weston, Florida. Unfortunately, the lot and expiration dates are not readable.*
FDA Label Image

Teyro-carton-label-60-ml (Carboplatin Injection Container Label 600mg)

FDA Label Image

Image (Carboplatin Injection Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.